Institute for Cancer Research
Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has at present seven research departments and more than 230 employees. More than half of the staff are externally funded. Many of the researchers have national and international commissions and ongoing collaborations.
The research at the Institute was collectively described as "very good, on the border of outstanding" by an international panel evaluating Norwegian biomedical research on behalf of The Norwegian Research Council.
Scientific director
Scientific production - Institute for Cancer Research
| PubMed articles | Doctoral theses | |
| 2010 | so far | |
| 2009 | 191 | 22 |
| 2008 | 184 | 11 |
| 2007 | 161 | 16 |
| 2006 | 176 | 12 |
| 2005 | 154 | 12 |
The Institute is engaged in both basic and translational cancer research involving experimental research on model organisms from various evolutionary levels as well as human material from all types of cells and tissues. The co-localisation with a large cancer hospital fulfils the premises for advanced medical research across sciences, a necessity towards the goals of individualised diagnostics and treatment for cancer patients.
Go back
Print this page
E-mail this pageMar 8, 2010
21st Meeting of the European Association for Cancer Research, 26 - 29 June 2010
Feb 25, 2010
Latest publications
Inst. for Cancer Research
PI3K-AKT-mTOR pathway is dominant over androgen receptor signaling in prostate cancer cells
Cell Oncol, 32 (1), 11-27
PubMed 20203370
Regulators of cyclin-dependent kinases are crucial for maintaining genome integrity in S phase
J Cell Biol (in press)
PubMed 20194642
Coexpression and nuclear colocalization of metastasis-promoting protein S100A4 and p53 without mutual regulation in colorectal carcinoma
Amino Acids (in press)
PubMed 20191297
Selected publications
Journal Impact Factor > 5, first or last author from the Institute for Cancer Research
p62, an autophagy hero or culprit?
Nat Cell Biol, 12 (3), 207-9
PubMed 20190829
(Impact 17.8)
Genomic Changes in Chromosomes 10, 16, and X in Malignant Peripheral Nerve Sheath Tumors Identify a High-Risk Patient Group
J Clin Oncol (in press)
PubMed 20159821
(Impact 17.2)
SNPs in genes coding for ROS metabolism and signalling in association with docetaxel clearance
Pharmacogenomics J (in press)
PubMed 20157331
(Impact 5.4)
